Middle East & Africa Animal Healthcare Market to Surpass US$ 5,521.4 Million by 2027 - Coherent Market Insights

Middle East & Africa Animal Healthcare Market, By Product Type (Anti-infective, Anti-inflammatory, Vaccines (FMD Vaccines, Rabies Vaccines, and Others), Hormones & Substitutes, and Others), By Animal Type (Livestock (Bovine, Porcine, Ovine, and Poultry), and Companion (Canine and Feline)), By Route of Administration (Oral and Parenteral), By Disease Indication (Viral Diseases, Bacterial Diseases, Fungal Diseases, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, and Online Pharmacies), and By Region (Middle East and Africa), is estimated to be valued at US$ 3,883.0 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Key players in the market are focusing on launch of animal healthcare products, which is expected to support growth of the market. For instance, in August 2017, Boehringer Ingelheim announced the launch of Centragard, a transdermal solution for the treatment and control of three of the most common intestinal parasites of cats such as hookworms, roundworms, and tapeworms.

Similarly, in 2019, Bayer Animal Health announced the launch of Coraxis, a topical solution for dogs, for the prevention of heartworm disease and to control hookworms, roundworms, and whipworms.

Middle East & Africa Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic.

The Food and Agriculture Organization of the United Nations provided guidelines to mitigate the impact of the COVID-19 pandemic on livestock production and animal health, which included the following recommendations for the livestock farmers to prevent spread of the coronavirus infection.

• Communication with professional service providers such as milk collectors and suppliers of feed, and consumables should be established to find solutions to secure supplies, inputs, and services
• Communication through producer cooperatives or farmers associations for obtaining necessary exemptions for mobilization of animals, products, and personnel
• Explore alternative sales channels such as online sales, e-commerce, and direct sales, and use point-to-point transportation to deliver livestock and related products to buyers
• The farmers should obtain latest information on the evolving COVID-19 situation from trusted sources such as radio programs provided by local governments, official news releases, livestock market officers, veterinary pharmacies, farmers associations, and others
• Implementation of practical biosafety and biosecurity measures to prevent human contamination with COVID-19 on the farm. These measures include:
  • Installation of footbaths and changing the disinfectant frequently
  • A designated area should be maintained for external visitors; visitor interactions with farm workers should be restricted
  • Consultation with animal health professionals to improve biosecurity and biosafety in the farm

Browse 75 Market Data Tables and 44 Figures spread through 244 Pages and in-depth TOC on “Animal Healthcare Market”- Middle East & Africa  Forecast to 2027, By Product Type (Anti-infective, Anti-inflammatory, Vaccines (FMD Vaccines, Rabies Vaccines, and Others), Hormones & Substitutes, and Others), By Animal Type (Livestock (Bovine, Porcine, Ovine, and Poultry), and Companion (Canine and Feline)), By Route of Administration (Oral and Parenteral), By Disease Indication (Viral Diseases, Bacterial Diseases, Fungal Diseases, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, and Online Pharmacies), and By Region (Middle East and Africa)

To know the latest trends and insights prevalent in the Middle East & Africa animal healthcare market, click the link below:

https://www.coherentmarketinsights.com/market-insight/middle-east-and-africa-animal-healthcare-market-3019

Middle East & Africa animal healthcare market is expected to witness significant growth due to the increasing funding and investment through public-private collaborations. For instance, in October 2018, The African Livestock Productivity and Health Advancement (A.L.P.H.A.), in collaboration with Zoetis, received US$ 14.4 Mn grant from the Bill & Melinda Gates Foundation to improve animal health in the region.                                   

Key Takeaways of the Middle East & Africa Animal Healthcare Market:

• The Middle East & Africa animal healthcare market is expected to exhibit a CAGR of 5.2% during the forecast period, owing to increasing product launches by market players. For instance, in May 2017, Ceva Santé Animale launched Cevac Ibird vaccine in Egypt for active immunization of chicken from infectious bronchitis.
• Among product type, the hormones & substitutes segment accounted for largest market share in 2019, owing to increased rate of livestock farming. According to the Census of Commercial Agriculture report, South Africa, published on March 24, 2020, livestock farming occupied the largest proportion of farms (33.9% of the total) in South Africa in 2017.
• Among animal type, livestock segment accounted for the largest market share in 2019, owing to an increasing number of livestock animals in the Middle East and Africa. According to The Food and Agricultural Organization of the United Nation report, in 2018, over 80% of the global sheep and goat population was present in Africa, Middle East, and Asia.
• Key players operating in the Middle East & Africa animal healthcare market include Zoetis Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva, Bayer AG, Evonik Industries AG, and Archer Daniels Midland Company